Bladder-Sparing Hypofractionated Intensity Modulated Radiation Therapy plus Weekly Gemcitabine in Patients with Invasive Bladder Cancer

被引:1
|
作者
Alrashidi, S. M. [1 ]
Souhami, L. [1 ]
Cury, F. [1 ]
Vanhuyse, M. [1 ]
Aprikian, A. [1 ]
Duclos, M. [1 ]
Rajan, R. [1 ]
Tanguay, S. [1 ]
Faria, S. L. [1 ]
Kassouf, W. [2 ]
机构
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
关键词
D O I
10.1016/j.ijrobp.2018.07.444
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SU_21_2200
引用
收藏
页码:E84 / E84
页数:1
相关论文
共 50 条
  • [1] Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results
    De Souza, T. Y. T.
    Souhami, L.
    Asso, R. N.
    Martinez, C.
    Kassouf, W.
    Saleh, R. R.
    Faria, S. L.
    Duclos, M.
    Rajan, R.
    Aprikian, A.
    Tanguay, S.
    Sanchez-Salas, R.
    Cury, F. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E523 - E523
  • [2] Bladder-sparing trimodal therapy for muscle invasive bladder cancer
    Khalifa, J.
    Roumiguie, M.
    Pouessel, D.
    Sargos, P.
    CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 771 - 778
  • [3] Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer
    Turgeon, Guy-Anne
    Souhami, Luis
    Cury, Fabio L.
    Faria, Sergio L.
    Duclos, Marie
    Sturgeon, Jeremy
    Kassouf, Wassim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 326 - 331
  • [4] HYPOFRACTIONATED INTENSITY MODULATED RADIATION THERAPY AND WEEKLY GEMCITABINE IS AN EFFECTIVE AND SAFE CURATIVE TREATMENT IN MUSCLE INVASIVE BLADDER CANCER: LONG-TERM RESULTS
    de Souza, Tomas Yokoo Teodoro
    Souhami, Luis
    Asso, Rie Nadia
    Martinez, Constanza
    Kassouf, Wassim
    Aprikian, Armen
    Saleh, Ramy
    Faria, Sergio
    Duclos, Marie
    Tsui, James
    Salas, Rafael Sanchez
    Cury, Fabio L.
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S14 - S14
  • [5] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [6] PATTERN OF METASTATIC SPREAD AFTER BLADDER-SPARING THERAPY FOR INVASIVE BLADDER CANCER
    Raup, Valary
    Eswara, Jairam
    Ozambela, Manuel
    McDougal, W. Scott
    JOURNAL OF UROLOGY, 2016, 195 (04): : E769 - E769
  • [7] Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer
    Ben -David, Reuben
    Galsky, Matthew D.
    Sfakianos, John P.
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (07) : 686 - 697
  • [8] Elective Bladder-Sparing Treatment for Muscle Invasive Bladder Cancer
    Lendinez-Cano, G.
    Rico-Lopez, J.
    Moreno, S.
    Fernandez Parra, E.
    Gonzalez-Almeida, C.
    Camacho Martinez, E.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (01): : 7 - 13
  • [9] Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer
    de Angelis, Mario
    Basile, Giuseppe
    Scornajenghi, Carlo Maria
    Asero, Vincenzo
    Del Giudice, Francesco
    Moschini, Marco
    CURRENT OPINION IN UROLOGY, 2023, 33 (05) : 354 - 359
  • [10] Bladder-sparing therapy for muscle-infiltrating bladder cancer
    Vito Pansadoro
    Paolo Emiliozzi
    Nature Clinical Practice Urology, 2008, 5 : 368 - 375